|
|
 Purchase CD >>
MicroRNA Regulation in 5-FU Treated Pancreatic Cancer Cells
Bao-Ling Adam, Assistant Professor, Center for Biotechnology and Genomic Medicine,
Medical College of Georgia
Cloning miRNAs in the Marsupial Cloning miRNAs in the Marsupial Monodelphis Monodelphis Domestica
Mark Behlke, Vice President, Integrated DNA Technologies
Alteration of Cell Phenotype through the Stable Ectopic Expression of microRNAs
Graham Brock, Director, Target and Drug Discovery, Ordway Research Institute and
miRNAcor
Labeling Methods Impact miRNA Profiling Results
Shannon Bruse, Senior Scientist, Mirus Bio Corporation
Potential use of RNAi on Human Skin
Christine Collin-Djangoné, Project Manager, L'Oréal Research
Argonaute Proteins in microRNA Biogenesis
Sven Diederichs, Research Fellow, Harvard Medical School
FANA-Modified Nucleic Acids as Versatile RNA-Targeting Agents
Nicolay Ferrari, Director Pharmacology, Topigen Pharmaceuticals
The Role of the CMO in the Large Scale Manufacture of siRNA Duplexes
Kevin Fettes, Process Development Group Leader, Avecia Biotechnology
Transfection Using Magnetic Nanostructures
Sarah Fredriksson, CEO and Founder, Genovis
Downregulation of microRNA Contributes to Altered Gene Expression in Heart Failure
Sadakatsu Ikeda, Research Fellow, Children's Hospital Boston/Harvard Medical
School
Development of RNAi-Based Therapeutics for Hepatitis C
Brian Johnston, Chief Executive Officer/President, SomaGenics
Intra-Axonal RNA Interference: Regulation of Intra-Axonal mRNA Translation in Regenerating Axons
Alexander Murashov, Associate Professor, East Carolina University
Forecasting Technology and Marketplace Trends in RNAi
Gary Oosta, Chief Scientific Officer, Oval Ideas
Cellaxess®HT - Automated Transfection System for Genome Wide RNAi Screening
Johan Pihl, Project Manager, Cellectricon
Applications of RNAi to Functional Target Validation in Cellular Disease Models of AD
Giuseppe Pollio, Principal Scientist, Siena Biotech
Epigenetics, MicroRNA, and RNAi Therapeutics: Market Snapshots
Enal Razvi, Biotechnology Analyst, Select Biosciences
Molecular Correlates of Prostate Cancer Subtypes
Sunita Setlur, Post Doctoral Fellow, Brigham and Women’s Hospital, Harvard Medical
School
|
|
|